Education
About Us
Working with TipRanks
Follow Us
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
See the Price Targets and Ratings of:
IGS1 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ascendiant
€3.65→€3.87
Buy
1387.30%
Upside
Reiterated
08/25/25
Current valuation attractive: We are maintaining our Buy rating, but raising our 12‐month price target to $4.50 from $4.25, based on a NPV analysis, representing significant upside from the current share price.
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Ascendiant
€3.65→€3.87
Buy
1387.30%
Upside
Reiterated
08/25/25
Current valuation attractive: We are maintaining our Buy rating, but raising our 12‐month price target to $4.50 from $4.25, based on a NPV analysis, representing significant upside from the current share price.
Best Analysts Covering IGC Pharma
1 Month
xxx
Success Rate
4/6 ratings generated profit
Average Return
+3.15%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.15% per trade.
3 Months
xxx
Success Rate
3/6 ratings generated profit
Average Return
+5.57%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.57% per trade.
1 Year
Success Rate
3/6 ratings generated profit
Average Return
-5.95%
reiterated a buy rating 4 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -5.95% per trade.
2 Years
xxx
Success Rate
1/6 ratings generated profit
Average Return
-15.32%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -15.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IGS1 Analyst Recommendation Trends
Rating
Apr 25
Jul 25
Aug 25
Oct 25
Nov 25
Strong Buy
0
0
1
1
1
Buy
0
0
0
0
0
Hold
5
13
13
12
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
13
14
13
6
Each month's total comprises the sum of three months' worth of ratings.
IGS1 Stock Forecast FAQ
What is DE:IGS1’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:IGS1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:IGS1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IGC Pharma a Buy, Sell or Hold?
Currently, no data Available
What is IGC Pharma’s share price target?
Currently, no data Available
What do analysts say about IGC Pharma?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of IGC Pharma?
To buy shares of DE:IGS1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.